| ESVS guidelines. Invasive treatment for carotid stenosis: indications, techniques | European Journal of Vascular and Endovascular Surgery | 2009 | 458 |
| Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension | European Heart Journal | 2006 | 244 |
| Orlistat-associated adverse effects and drug interactions: a critical review | Drug Safety | 2008 | 217 |
| Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? | Metabolism: Clinical and Experimental | 2006 | 208 |
| Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study | Current Medical Research and Opinion | 2006 | 191 |
| Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms | International Journal of Cardiology | 2008 | 167 |
| European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV | HIV Medicine | 2008 | 154 |
| Statin-fibrate combination: therapy for hyperlipidemia: a review | Current Medical Research and Opinion | 2003 | 139 |
| The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions | Current Medical Research and Opinion | 2005 | 138 |
| Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy | Current Medical Research and Opinion | 2007 | 125 |
| Different methods of creatinine measurement significantly affect MELD scores | Liver Transplantation | 2007 | 123 |
| Review article: renal function assessment in cirrhosis - difficulties and alternative measurements | Alimentary Pharmacology and Therapeutics | 2007 | 117 |
| Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study | Nephrology Dialysis Transplantation | 2007 | 114 |
| The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study | Diabetes, Obesity and Metabolism | 2005 | 114 |
| Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort | Angiology | 2007 | 113 |
| Prevention and treatment of the metabolic syndrome | Angiology | 2004 | 109 |
| Female liver transplant recipients with the same GFR as male recipients have lower MELD scores--a systematic bias | American Journal of Transplantation | 2007 | 106 |
| Matrix metalloproteinases and diabetic vascular complications | Angiology | 2005 | 106 |
| Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications | Rheumatology International | 2011 | 105 |
| Clinical relevance of postprandial lipaemia | Current Medicinal Chemistry | 2005 | 104 |
| Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism | Expert Opinion on Pharmacotherapy | 2008 | 94 |
| Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients | Liver International | 2011 | 92 |
| Serum uric acid as an independent predictor of early death after acute stroke | Circulation Journal | 2007 | 91 |
| Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemia | Current Pharmaceutical Design | 2005 | 89 |
| Significance of plasma N-terminal pro-brain natriuretic peptide in patients with systemic sclerosis-related pulmonary arterial hypertension | Respiratory Medicine | 2003 | 84 |
